Literature DB >> 24439166

Familial benign frontotemporal deterioration with C9ORF72 hexanucleotide expansion.

Estrella Gómez-Tortosa1, Soledad Serrano2, María de Toledo2, Julián Pérez-Pérez3, M José Sainz4.   

Abstract

BACKGROUND: In recent years, a benign variant of frontotemporal lobar degeneration (FTLD) has been recognized, with a particularly slow progression of cognitive deficits and scarce frontotemporal atrophy or hypoperfusion in neuroimaging studies. Patients with FTLD have been considered "phenocopies," with an underlying nondegenerative neurologic process.
RESULTS: We report the first family with three affected members having benign FTLD associated with C9ORF72 gene hexanucleotide expansion. Onset of symptoms occurred during the fifth decade, with naming and memory problems as the main features. Two siblings have stabilized at mild cognitive impairment or incipient dementia for more than a decade, and remain quite independent for their activities of daily living at the current ages of 69 and 65 years, respectively. Their mother's cognitive deterioration evolved slowly during >30 years.
CONCLUSION: This family demonstrates that a benign evolution can be part of the growing spectrum of clinical phenotypes associated with neurodegenerative diseases caused by the C9ORF72 hexanucleotide expansion. Screening of this genetic marker should be considered in cases with this slow deterioration, especially if there is a family history.
Copyright © 2014 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C9ORF72 gene; Frontotemporal dementia; Hexanucleotide expansion; Neurogenetics

Mesh:

Substances:

Year:  2014        PMID: 24439166     DOI: 10.1016/j.jalz.2013.09.013

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  7 in total

Review 1.  Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Suvi Häkkinen; Stephanie A Chu; Suzee E Lee
Journal:  Neurobiol Dis       Date:  2020-09-02       Impact factor: 5.996

2.  Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophy.

Authors:  Ignacio Illán-Gala; Victor Montal; Sergi Borrego-Écija; Eduard Vilaplana; Jordi Pegueroles; Daniel Alcolea; Belén Sánchez-Saudinós; Jordi Clarimón; Janina Turón-Sans; Nuria Bargalló; Sofía González-Ortiz; Howard J Rosen; Maria Luisa Gorno-Tempini; Bruce L Miller; Albert Lladó; Ricard Rojas-García; Rafael Blesa; Raquel Sánchez-Valle; Alberto Lleó; Juan Fortea
Journal:  Brain       Date:  2019-04-01       Impact factor: 13.501

3.  Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis.

Authors:  Jonathan D Rohrer; Jennifer M Nicholas; David M Cash; John van Swieten; Elise Dopper; Lize Jiskoot; Rick van Minkelen; Serge A Rombouts; M Jorge Cardoso; Shona Clegg; Miklos Espak; Simon Mead; David L Thomas; Enrico De Vita; Mario Masellis; Sandra E Black; Morris Freedman; Ron Keren; Bradley J MacIntosh; Ekaterina Rogaeva; David Tang-Wai; Maria Carmela Tartaglia; Robert Laforce; Fabrizio Tagliavini; Pietro Tiraboschi; Veronica Redaelli; Sara Prioni; Marina Grisoli; Barbara Borroni; Alessandro Padovani; Daniela Galimberti; Elio Scarpini; Andrea Arighi; Giorgio Fumagalli; James B Rowe; Ian Coyle-Gilchrist; Caroline Graff; Marie Fallström; Vesna Jelic; Anne Kinhult Ståhlbom; Christin Andersson; Håkan Thonberg; Lena Lilius; Giovanni B Frisoni; Michela Pievani; Martina Bocchetta; Luisa Benussi; Roberta Ghidoni; Elizabeth Finger; Sandro Sorbi; Benedetta Nacmias; Gemma Lombardi; Cristina Polito; Jason D Warren; Sebastien Ourselin; Nick C Fox; Martin N Rossor; Giuliano Binetti
Journal:  Lancet Neurol       Date:  2015-02-04       Impact factor: 44.182

4.  Clinical Update on C9orf72: Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, and Beyond.

Authors:  Dario Saracino; Isabelle Le Ber
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Frontotemporal Lobe Degeneration as Origin of Scans Without Evidence of Dopaminergic Deficit.

Authors:  Manuel Menéndez-González; Tania Álvarez-Avellón; José M Salas-Pacheco; Benito de Celis-Alonso; Kathryn A Wyman-Chick; Oscar Arias-Carrión
Journal:  Front Neurol       Date:  2018-05-24       Impact factor: 4.003

Review 6.  Phenocopy syndrome of behavioral variant frontotemporal dementia: a systematic review.

Authors:  Elizabeth Sakamoto Valente; Paulo Caramelli; Leandro Boson Gambogi; Luciano Inácio Mariano; Henrique Cerqueira Guimarães; Antônio Lúcio Teixeira; Leonardo Cruz de Souza
Journal:  Alzheimers Res Ther       Date:  2019-04-01       Impact factor: 6.982

7.  Structural and functional brain abnormalities place phenocopy frontotemporal dementia (FTD) in the FTD spectrum.

Authors:  Rebecca M E Steketee; Rozanna Meijboom; Esther E Bron; Robert Jan Osse; Inge de Koning; Lize C Jiskoot; Stefan Klein; Frank Jan de Jong; Aad van der Lugt; John C van Swieten; Marion Smits
Journal:  Neuroimage Clin       Date:  2016-04-10       Impact factor: 4.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.